TIM-1 Rabbit Polyclonal Antibody
To Order: garrett@bioworldantibodies.com
 Anti-TIM 3/HAVCR2 Antibody |
|
A00657-1 |
BosterBio |
100ug/vial |
EUR 352.8 |
 HRP-Goat Anti-Rabbit Secondary Antibody |
|
A12004 |
EpiGentek |
|
|
 TIM-1 Antibody |
|
3811-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma. |
TIM-1 Antibody |
|
3811-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma. |
TIM-1 Antibody |
|
3809-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma. |
TIM-1 Antibody |
|
3809-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma. |
TIM-1 Antibody |
|
24416-100ul |
SAB |
100ul |
EUR 468 |
TIM-1 Antibody |
|
24417-100ul |
SAB |
100ul |
EUR 468 |
 Goat Anti-Rabbit Secondary Antibody, Biotin Conjugated |
|
A12001 |
EpiGentek |
|
|
 Oncogene TIM Polyclonal Antibody |
|
ABP56598-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of Oncogene TIM from Human, Mouse, Rat. This Oncogene TIM antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Oncogene TIM at AA range: 160-240 |
Oncogene TIM Polyclonal Antibody |
|
ABP56598-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of Oncogene TIM from Human, Mouse, Rat. This Oncogene TIM antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Oncogene TIM at AA range: 160-240 |
Oncogene TIM Polyclonal Antibody |
|
ABP56598-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of Oncogene TIM from Human, Mouse, Rat. This Oncogene TIM antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Oncogene TIM at AA range: 160-240 |
 Polyclonal Tim-3 Antibody |
|
APR00202G |
Leading Biology |
0.1mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Tim-3 . This antibody is tested and proven to work in the following applications: |
 Polyclonal TIM-4 Antibody |
|
APR06408G |
Leading Biology |
0.1 mg |
EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIM-4 . This antibody is tested and proven to work in the following applications: |
Polyclonal TIM-4 Antibody |
|
APR06409G |
Leading Biology |
0.1 mg |
EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIM-4 . This antibody is tested and proven to work in the following applications: |
Oncogene TIM Polyclonal Antibody |
|
ES7597-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against Oncogene TIM from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Oncogene TIM Polyclonal Antibody |
|
ES7597-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against Oncogene TIM from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA |
 Anti-TIM-1 antibody |
|
STJ98725 |
St John's Laboratory |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to TIM-1. |
 TIM antibody |
|
10R-10306 |
Fitzgerald |
100 ug |
EUR 522 |
|
Description: Mouse monoclonal TIM antibody |
TIM antibody |
|
10R-10307 |
Fitzgerald |
100 ug |
EUR 522 |
|
Description: Mouse monoclonal TIM antibody |
 TIM-1 Peptide |
|
43-672P |
ProSci |
0.1 mg |
EUR 405.6 |
TIM-1 Peptide |
|
3811P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (IN) TIM-1 peptide |
TIM-1 Peptide |
|
3809P |
ProSci |
0.05 mg |
EUR 197.7 |
|
Description: (NT) TIM-1 peptide |
 anti-TIM 1 |
|
YF-PA18329 |
Abfrontier |
50 ug |
EUR 435.6 |
|
Description: Mouse polyclonal to TIM 1 |
anti-TIM 1 |
|
YF-PA18330 |
Abfrontier |
100 ug |
EUR 483.6 |
|
Description: Rabbit polyclonal to TIM 1 |
anti-TIM 1 |
|
YF-PA26016 |
Abfrontier |
50 ul |
EUR 400.8 |
|
Description: Mouse polyclonal to TIM 1 |
) Polyclonal Goat Anti-TIM-1 Antibody (internal region) |
|
APR11107G |
Leading Biology |
0.1mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-TIM-1 (internal region). This antibody is tested and proven to work in the following applications: |
 Anti-TIM 1/HAVCR1 Antibody |
|
A01306 |
BosterBio |
100ug/vial |
EUR 352.8 |
Anti-TIM 1/HAVCR1 Antibody |
|
PA1624 |
BosterBio |
100ug/vial |
EUR 400.8 |
Anti-TIM 1/HAVCR1 Antibody |
|
PA1632 |
BosterBio |
100ug/vial |
EUR 400.8 |
Anti-TIM 1/HAVCR1 Antibody |
|
RP1093 |
BosterBio |
100ug/vial |
EUR 352.8 |
 AssayMax ELISA Kit) Human Triosephosphate Isomerase (TIM) AssayMax ELISA Kit |
|
ET3025-1 |
AssayPro |
96 Well Plate |
EUR 500.4 |
 TIM-4 Antibody |
|
3813-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma. |
TIM-4 Antibody |
|
3813-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma. |
TIM-4 Antibody |
|
3815-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma. |
TIM-4 Antibody |
|
3815-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma. |
TIM-4 Antibody |
|
24418-100ul |
SAB |
100ul |
EUR 468 |
TIM-4 Antibody |
|
24419-100ul |
SAB |
100ul |
EUR 468 |
 TIM-3 Antibody |
|
8659-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: The immune checkpoint protein TIM-3 is a member of the immunoglobulin superfamily and TIM family of proteins that was initially identified as a specific marker of fully differentiated IFN-γ producing CD4 T helper 1 (Th1) and CD8 cytotoxic cells. It is a Th1-specific cell surface protein that regulates macrophage activation and negatively regulates Th1-mediated auto- and alloimmune responses, and is also highly expressed on regulatory T cells, monocytes, macrophages, and dendritic cells (1). TIM-3 and PD-1 are co-expressed on most CD4 and CD8 T cells infiltrating solid tumors or in hematologic malignancy in mice; blocking TIM-3 in conjugation with a PD-1 blockade increases the functionality of exhausted T cells and synergizes with to inhibit tumor growth (2,3). |
TIM-3 Antibody |
|
8659-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: The immune checkpoint protein TIM-3 is a member of the immunoglobulin superfamily and TIM family of proteins that was initially identified as a specific marker of fully differentiated IFN-γ producing CD4 T helper 1 (Th1) and CD8 cytotoxic cells. It is a Th1-specific cell surface protein that regulates macrophage activation and negatively regulates Th1-mediated auto- and alloimmune responses, and is also highly expressed on regulatory T cells, monocytes, macrophages, and dendritic cells (1). TIM-3 and PD-1 are co-expressed on most CD4 and CD8 T cells infiltrating solid tumors or in hematologic malignancy in mice; blocking TIM-3 in conjugation with a PD-1 blockade increases the functionality of exhausted T cells and synergizes with to inhibit tumor growth (2,3). |
 Tim-3 Antibody |
|
3808-100 |
Biovision |
each |
EUR 379.2 |
Tim-3 Antibody |
|
3808-30T |
Biovision |
each |
EUR 175.2 |
 Tim-1 Recombinant Protein |
|
90-546 |
ProSci |
100 ug |
EUR 752.1 |
|
Description: The TIM (T cell/transmembrane, immunoglobulin and mucin) family plays a critical role in regulating immune responses, including allergy, asthma, transplant tolerance, autoimmunity and the response to viral infections. The unique structure of TIM immunoglobulin variable region domains allows highly specific recognition of phosphatidylserine (PtdSer), exposed on the surface of apoptotic cells. TIM-1 (T cell-immunoglobulinmucin; also KIM-1 and HAVcr-1) is a 100 kDa, type I transmembrane glycoprotein member of the TIM family of immunoglobulin superfamily molecules. There are two cytoplasmic alternate splice forms of TIM1. One is a long (359 aa) kidney form termed TIM-1b, and one is a short (334 aa) liver form termed TIM-1a. TIM-1, important for asthma and allergy, is preferentially expressed on T-helper 2 (Th2) cells and functions as a potent costimulatory molecule for T cell activation. |
Tim-1 Recombinant Protein |
|
90-547 |
ProSci |
100 ug |
EUR 752.1 |
|
Description: The TIM (T cell/transmembrane, immunoglobulin and mucin) family plays a critical role in regulating immune responses, including allergy, asthma, transplant tolerance, autoimmunity and the response to viral infections. The unique structure of TIM immunoglobulin variable region domains allows highly specific recognition of phosphatidylserine (PtdSer), exposed on the surface of apoptotic cells. Tim-1 (KIM-1; HAVcr-1) is a 100 kDa, type I transmembrane glycoprotein member of the TIM family of immunoglobulin superfamily molecules. There are two cytoplasmic alternate splice forms of Tim-1. One is a long (359 aa) kidney form termed Tim-1b, and one is a short (334 aa) liver form termed Tim-1a. Tim-1, important for asthma and allergy, is preferentially expressed on T-helper 2 (Th2) cells and functions as a potent costimulatory molecule for T cell activation. |
) Anti-TIM 1 (2G11) |
|
YF-MA18139 |
Abfrontier |
100 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to TIM 1 |
) Anti-TIM 1 (1E5) |
|
YF-MA11444 |
Abfrontier |
100 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to TIM 1 |
) Anti-TIM 1 (2B9) |
|
YF-MA11445 |
Abfrontier |
100 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to TIM 1 |
 Tim-1, Human Recombinant |
|
P1351-10 |
Biovision |
each |
EUR 196.8 |
Tim-1, Human Recombinant |
|
P1351-50 |
Biovision |
each |
EUR 627.6 |
 Tim-1, Mouse Recombinant |
|
P1354-10 |
Biovision |
each |
EUR 196.8 |
Tim-1, Mouse Recombinant |
|
P1354-50 |
Biovision |
each |
EUR 627.6 |
) Polyclonal TIMD4 / TIM4 / TIM-4 Antibody (Internal) |
|
APR02384G |
Leading Biology |
0.05mg |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIMD4 / TIM4 / TIM-4 (Internal). This antibody is tested and proven to work in the following applications: |
) Polyclonal HAVCR2 / TIM-3 Antibody (aa176-194) |
|
APR03015G |
Leading Biology |
0.05ml |
EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HAVCR2 / TIM-3 (aa176-194). This antibody is tested and proven to work in the following applications: |
 Histone H3K4 Methylation Antibody Panel Pack |
|
C10005 |
EpiGentek |
|
|
 Histone H3K9 Methylation Antibody Panel Pack |
|
C10006 |
EpiGentek |
|
|
 Histone H3K27 Methylation Antibody Panel Pack |
|
C10007 |
EpiGentek |
|
|
 Histone H3K36 Methylation Antibody Panel Pack |
|
C10008 |
EpiGentek |
|
|
 Histone H3K79 Methylation Antibody Panel Pack |
|
C10009 |
EpiGentek |
|
|
 Histone H4K20 Methylation Antibody Panel Pack |
|
C10012 |
EpiGentek |
|
|
 Histone H4 Acetylation Antibody Panel Pack |
|
C10013 |
EpiGentek |
|
|
 Histone H3 Phosphorylation Antibody Panel Pack |
|
C10014 |
EpiGentek |
|
|
 Histone H3R2 Methylation Antibody Panel Pack |
|
C10015 |
EpiGentek |
|
|
 Histone H3R8 Methylation Antibody Panel Pack |
|
C10016 |
EpiGentek |
|
|
 Histone H3R17 Methylation Antibody Panel Pack |
|
C10017 |
EpiGentek |
|
|
 Histone H3R26 Methylation Antibody Panel Pack |
|
C10018 |
EpiGentek |
|
|
 Histone H4R3 Methylation Antibody Panel Pack |
|
C10019 |
EpiGentek |
|
|
 HRP-Goat Anti-Mouse Secondary Antibody |
|
A12003 |
EpiGentek |
|
|
 DNA Methylation Antibody Panel Pack I |
|
C20000 |
EpiGentek |
|
|
 Histone H3 Acetylation Antibody Panel Pack I |
|
C10010 |
EpiGentek |
|
|
 Histone H3 Acetylation Antibody Panel Pack II |
|
C10011 |
EpiGentek |
|
|
 Goat Anti-Rat Secondary Antibody, Biotin Conjugated |
|
A12002 |
EpiGentek |
|
|
 Antibody) Triosephosphate Isomerase (TIM) Antibody |
|
20-abx141692 |
Abbexa |
-
EUR 444.00
-
EUR 727.20
-
EUR 360.00
|
|
|
|
Triosephosphate Isomerase (TIM) Antibody |
|
20-abx018098 |
Abbexa |
|
|
|
|
Triosephosphate Isomerase (TIM) Antibody |
|
abx018099-100ug |
Abbexa |
100 ug |
EUR 460.8 |
|
|
 Anti-Oncogene TIM antibody |
|
STJ94826 |
St John's Laboratory |
200 µl |
EUR 236.4 |
|
Description: Rabbit polyclonal to Oncogene TIM. |
 TIM-3 Antibody / HAVCR2 |
|
V8495-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8495-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8495SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8724-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8724-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8724SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8753-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8753-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8753SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8754-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8754-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8754SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8755-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8755-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8755SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8766-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-3 Antibody / HAVCR2 |
|
V8766-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
|
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation. |
TIM-1 Rabbit Polyclonal Antibody
